OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Unknown
(1)
Proteomics
(1)
Organisms
Alphavirus
(1)
Anemia
(1)
Archaea
(1)
Bacteria
(1)
Betaherpesvirinae
(1)
Borrelia
(1)
Chlamydomonas reinhardtii
(1)
Chlorella vulgaris
(1)
Clostridium perfringens
(1)
Dengue virus
(1)
Eukaryota
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Kamptonema sp.
(1)
Listeria monocytogenes
(1)
Mammarenavirus
(1)
Miscanthus x giganteus
(1)
Mycobacterium tuberculosis
(1)
Orthoflavivirus
(1)
Pseudomonas aeruginosa
(1)
Rattus
(1)
Sarbecovirus
(1)
Severe acute respiratory syndrome coronavirus 2
(1)
Staphylococcus aureus
(1)
Streptococcus pneumoniae
(1)
Viruses
(1)
Repository
pride
(1)
Technology Type
Data-dependent acquisition
(1)
Mass Spectrometry
(1)
Publication Date
2025
(1)
Release Date
2022
(1)
Lab affiliation
Institute of Parasitology, University of Bern, Switzerland
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Differentially and constantly expressed proteins identified through proteomic analysis of different Toxoplasma gondii field isolates carried out upon short- or long-term in vitro culture
Comparison of the proteomes of Toxoplasma gondii field isolates after short-term or long-term in vitro culture
ORGANISM(S):
Toxoplasma gondii
2025-10-06
|
PXD067210
|
Pride
Target deconvolution
Model system
Patho-biodiversity
Eukaryote cell
Equivalence tests
Vaccine development
Cite
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
